• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用莫氏手术治疗隆突性皮肤纤维肉瘤。1例CD34免疫染色变异的病例。

Dermatofibrosarcoma protuberans treated with Mohs surgery. A case with CD34 immunostaining variability.

作者信息

Garcia C, Viehman G, Hitchcock M, Clark R E

机构信息

Dermatologic Surgery and Cutaneous Oncology Unit, Duke University Medical Center, Durham, North Carolina 27710, USA.

出版信息

Dermatol Surg. 1996 Feb;22(2):177-9. doi: 10.1111/j.1524-4725.1996.tb00503.x.

DOI:10.1111/j.1524-4725.1996.tb00503.x
PMID:8608381
Abstract

BACKGROUND

Immunohistochemical stains for CD34 antigen can help in differentiating dermatofibrosarcoma protuberans (DFSP) from other fibrohistiocytic tumors and in demarcating its surgical margins during Mohs surgery. However, variable expression of CD34 antigen in nodular areas can sometimes result in negative staining of tissue sections creating diagnostic and therapeutic dilemmas.

OBJECTIVE

To show the variable expression of CD34 antigen in a DFSP tumor.

METHODS

Case presentation of DFSP with immunohistochemical staining using the ABC peroxidase macromolecular complex.

RESULTS

Microscopic examination of paraffin-embedded sections showed CD34-negative DFSP tumor cells with positive staining of endothelial cells. On frozen sections at the time of surgery the tumor cells stained strongly positive for CD34.

CONCLUSION

This case demonstrates the variable expression of CD34 antigen by DFSP tumors and emphasizes the need to interpret with caution the results of these immunostains during Mohs surgery.

摘要

背景

CD34抗原的免疫组织化学染色有助于将隆突性皮肤纤维肉瘤(DFSP)与其他纤维组织细胞肿瘤区分开来,并在莫氏手术中划定其手术切缘。然而,结节区域中CD34抗原的表达可变,有时会导致组织切片染色阴性,从而产生诊断和治疗难题。

目的

展示CD34抗原在DFSP肿瘤中的可变表达。

方法

通过使用ABC过氧化物酶大分子复合物进行免疫组织化学染色对DFSP进行病例展示。

结果

石蜡包埋切片的显微镜检查显示,DFSP肿瘤细胞CD34染色阴性,而内皮细胞染色阳性。手术时的冰冻切片显示肿瘤细胞CD34染色强阳性。

结论

本病例证明了DFSP肿瘤中CD34抗原的可变表达,并强调在莫氏手术期间对这些免疫染色结果进行谨慎解读的必要性。

相似文献

1
Dermatofibrosarcoma protuberans treated with Mohs surgery. A case with CD34 immunostaining variability.采用莫氏手术治疗隆突性皮肤纤维肉瘤。1例CD34免疫染色变异的病例。
Dermatol Surg. 1996 Feb;22(2):177-9. doi: 10.1111/j.1524-4725.1996.tb00503.x.
2
Dermatofibrosarcoma protuberans.隆突性皮肤纤维肉瘤
Int J Dermatol. 1996 Dec;35(12):867-71. doi: 10.1111/j.1365-4362.1996.tb05053.x.
3
Bednar tumor (pigmented dermatofibrosarcoma protuberans) occurring in a site of prior immunization: immunochemical findings and therapy.发生于既往免疫接种部位的贝德纳瘤(色素性隆突性皮肤纤维肉瘤):免疫化学研究结果及治疗
J Am Acad Dermatol. 1999 Feb;40(2 Pt 2):315-7. doi: 10.1016/s0190-9622(99)70474-3.
4
Immunohistochemical characterization of dermatofibrosarcoma protuberans with practical applications for diagnosis and treatment.隆突性皮肤纤维肉瘤的免疫组织化学特征及其在诊断和治疗中的实际应用
J Am Acad Dermatol. 1997 Sep;37(3 Pt 1):438-44. doi: 10.1016/s0190-9622(97)70146-4.
5
Dermatofibrosarcoma protuberans: a clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors.隆突性皮肤纤维肉瘤:一项关于低级别与高级别(纤维肉瘤样)肿瘤的临床病理、免疫组化、遗传学(COL1A1-PDGFB)和治疗研究。
J Am Acad Dermatol. 2011 Sep;65(3):564-575. doi: 10.1016/j.jaad.2010.06.020. Epub 2011 May 12.
6
A comparison of frozen and paraffin sections in dermatofibrosarcoma protuberans.隆突性皮肤纤维肉瘤中冰冻切片与石蜡切片的比较。
Dermatol Surg. 1998 Sep;24(9):995-8. doi: 10.1111/j.1524-4725.1998.tb04293.x.
7
Dermatofibrosarcoma protuberans: dealing with slow Mohs procedures employing formalin-fixed, paraffin wax-embedded tissue in a busy diagnostic laboratory.隆突性皮肤纤维肉瘤:在繁忙的诊断实验室中处理采用福尔马林固定、石蜡包埋组织的缓慢莫氏手术。
Br J Biomed Sci. 2012;69(2):56-61.
8
Immunohistochemical margin control applied to Mohs micrographic surgical excision of dermatofibrosarcoma protuberans.免疫组织化学边缘控制应用于隆突性皮肤纤维肉瘤的莫氏显微外科切除。
J Dermatol Surg Oncol. 1994 Oct;20(10):687-9. doi: 10.1111/j.1524-4725.1994.tb00454.x.
9
Atrophic dermatofibrosarcoma protuberans: a case report and reappraisal of the literature.萎缩性隆突性皮肤纤维肉瘤:一例报告及文献再评价
Cutis. 2004 Oct;74(4):237-42.
10
Autoamputation of Dermatofibrosarcoma Protuberans: A Novel and Rare Presentation of a Familiar Entity.隆突性皮肤纤维肉瘤的自行截肢:一种常见疾病的新型罕见表现。
Int J Surg Pathol. 2019 Aug;27(5):531-534. doi: 10.1177/1066896919832658. Epub 2019 Feb 27.

引用本文的文献

1
Dermatofibrosarcoma Protuberans.隆突性皮肤纤维肉瘤
Curr Treat Options Oncol. 2017 Aug 10;18(9):56. doi: 10.1007/s11864-017-0498-5.
2
Dermatofibrosarcoma protuberans (DFSP): predictors of recurrence and the use of systemic therapy.隆突性皮肤纤维肉瘤(DFSP):复发的预测因素和系统治疗的应用。
Ann Surg Oncol. 2011 Feb;18(2):328-36. doi: 10.1245/s10434-010-1316-5. Epub 2010 Sep 16.
3
Immunohistochemistry in mohs micrographic surgery: a review of the literature.莫氏显微外科手术中的免疫组织化学:文献综述
J Clin Aesthet Dermatol. 2009 Jul;2(7):37-42.
4
Current treatment options in dermatofibrosarcoma protuberans.隆突性皮肤纤维肉瘤的当前治疗选择。
J Cancer Res Clin Oncol. 2009 May;135(5):653-65. doi: 10.1007/s00432-009-0550-3. Epub 2009 Feb 10.